XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.3
ORGANIZATION AND NATURE OF THE BUSINESS (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Financial assets $ 71,525,379           $ 71,525,379   $ 68,038,621
Net loss (3,349,204) $ (981,530) $ (459,863) $ (1,972,775) $ (1,241,256) $ 203,347 (4,790,597) $ (3,010,684)  
CANA Pharmaceutical Laboratories, S.A. ("Cana") [Member]                  
Financial assets 1,796,911           1,796,911    
Cash             5,331,120    
Fair value of common stock issued             138,667    
Fair value of total consideration transferred             5,469,787    
Inventory 297,340           297,340    
Property, plant and equipment 7,682,411           7,682,411    
Identifiable intangible assets 562,200           562,200    
Financial liabilities (3,235,233)           (3,235,233)    
Total identifiable net assets 7,103,629           7,103,629    
Bargain purchase gain 1,633,842           $ 1,633,842    
Net loss (604,790)                
Revenue $ 91,056